Stay updated on Pembrolizumab for HR+ Inflammatory Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for HR+ Inflammatory Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for HR+ Inflammatory Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Administrative site updates: a new revision entry (v3.4.2) and removal of an older funding notice; these changes do not affect the study details or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T14:21:42.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a government-funding notice banner indicating the NIH Clinical Center is open and where to check status updates (opm.gov). Updated the page revision from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T10:28:48.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added results posting information and new outcomes for the study, including DFS definitions and adverse-event metrics with follow-up times, and linked a PDF of the Study Protocol and SAP. The page's study documents section was updated and some prior analysis details were removed.
    Difference
    3%
    Check dated 2026-01-28T06:28:40.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and the previous v3.3.3 revision was removed, representing a minor technical update with no changes to study content or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:07:11.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    A new Locations section appears with Texas as a study site. The previous Texas Locations entry and the HHS Vulnerability Disclosure link were removed; the page revision updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T17:25:23.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The study results status changed from No Results Posted to Results Submitted, indicating that the trial results are now being prepared for posting. This affects the availability of outcome information for stakeholders reviewing the study.
    Difference
    0.1%
    Check dated 2025-12-16T10:13:44.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for HR+ Inflammatory Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for HR+ Inflammatory Breast Cancer Clinical Trial page.